MedTrace Logo

Effect of High-intensity Laser Therapy on Patients With Myogenic Temporomandibular Joint Dysfunction

NCT06495788 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-07-11

No results posted yet for this study

Summary

This study will be conducted to investigate the effect of high-intensity laser therapy on the temporalis and masseter muscles activity in patients with myogenic temporomandibular joint dysfunction.

Conditions

  • Temporomandibular Joint Dysfunction Syndrome

Interventions

DEVICE

High-intensity laser therapy (HILT)

* Pulsed high-intensity laser therapy (HILT) will be applied 3 sessions per week for 8 weeks with pulsed emission (1064 nm), very high peak power (3 kW), a short duration (120-150 ms), and low frequency (10-40 Hz).The probe is fixed vertically at 90° to the most painful points while the patients sit on a chair and wear safety eyewear. * Conventional treatment ( 3 days per week for 8 weeks).: in the form of * Hot pad: It will be used over the temporomandibular joint (TMJ) for 5 minutes at the beginning of each session. * Ultrasound therapy (US): it will be applied over the TMJ with pulsed intensity of 1.0 W/cm2 at a 1MHz frequency for 5 min/session. * TENS: one electrode is placed over the TMJ and the other just above the mandibular angle. it will be applied with a low frequency of 50 HZ, tolerable intensity for 15 minutes. * Exercise therapy: anterior, medial and lateral glide of the mandible. Each glide will be done 10-15 repetitions, 5-6 times in a session, 10 minutes as a total.

DEVICE

placebo high-intensity laser therapy

The same treatment procedure will be applied in the placebo group as in the experimental group, but the laser device is turned off during applications, in addition to the conventional treatment in the form of hot pad, US, TENS, and exercise therapy.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amir Saleh, professor · Cairo University

  • Naglaa Awais, PHD · Cairo University

  • Hala Hazzaa, professor · Al-Azhar University

  • Yasser Lasheen, PHD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-12
Primary Completion
2024-11-20
Completion
2024-12-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06495788 on ClinicalTrials.gov